561 related articles for article (PubMed ID: 18790021)
1. Impact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
Kerkerian-Le Goff L; Bacci JJ; Jouve L; Melon C; Salin P
Brain Res Bull; 2009 Feb; 78(2-3):80-4. PubMed ID: 18790021
[TBL] [Abstract][Full Text] [Related]
2. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
3. The search for a role of the caudal intralaminar nuclei in the pathophysiology of Parkinson's disease.
Lanciego JL; López IP; Rico AJ; Aymerich MS; Pérez-Manso M; Conte L; Combarro C; Roda E; Molina C; Gonzalo N; Castle M; Tuñón T; Erro E; Barroso-Chinea P
Brain Res Bull; 2009 Feb; 78(2-3):55-9. PubMed ID: 18790023
[TBL] [Abstract][Full Text] [Related]
4. Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.
Jouve L; Salin P; Melon C; Kerkerian-Le Goff L
J Neurosci; 2010 Jul; 30(29):9919-28. PubMed ID: 20660274
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
Oueslati A; Breysse N; Amalric M; Kerkerian-Le Goff L; Salin P
Eur J Neurosci; 2005 Dec; 22(11):2765-74. PubMed ID: 16324110
[TBL] [Abstract][Full Text] [Related]
6. Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia.
Bacci JJ; Kachidian P; Kerkerian-Le Goff L; Salin P
J Neuropathol Exp Neurol; 2004 Jan; 63(1):20-31. PubMed ID: 14748558
[TBL] [Abstract][Full Text] [Related]
7. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.
Stefani A; Peppe A; Pierantozzi M; Galati S; Moschella V; Stanzione P; Mazzone P
Brain Res Bull; 2009 Feb; 78(2-3):113-8. PubMed ID: 18812214
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus.
Bacci JJ; Absi el H; Manrique C; Baunez C; Salin P; Kerkerian-Le Goff L
Eur J Neurosci; 2004 Dec; 20(12):3331-41. PubMed ID: 15610165
[TBL] [Abstract][Full Text] [Related]
10. Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson's disease.
Kerkerian-Le Goff L; Jouve L; Melon C; Salin P
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S167-70. PubMed ID: 20082982
[TBL] [Abstract][Full Text] [Related]
11. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Turner MS; Gray TS; Mickiewicz AL; Napier TC
Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
Ochi M; Shiozaki S; Kase H
Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
[TBL] [Abstract][Full Text] [Related]
13. Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat.
Bacci JJ; Kerkerian-Le Goff L; Salin P
Eur J Neurosci; 2002 Jun; 15(12):1918-28. PubMed ID: 12099898
[TBL] [Abstract][Full Text] [Related]
14. [Effects of electrical stimulation of the parafascicular nucleus on the neuronal activities of the subthalamic nucleus and the ventromedial nucleus in rats].
Lin FK; Xin Y; Gao DM; Xiong Z; Chen JG
Sheng Li Xue Bao; 2007 Feb; 59(1):79-85. PubMed ID: 17294046
[TBL] [Abstract][Full Text] [Related]
15. Facing the lack of anti-phase oscillation in the parafascicular nucleus after dopamine depletion.
Tseng KY
Exp Neurol; 2009 Sep; 219(1):62-5. PubMed ID: 19501087
[TBL] [Abstract][Full Text] [Related]
16. The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states.
Smith Y; Raju D; Nanda B; Pare JF; Galvan A; Wichmann T
Brain Res Bull; 2009 Feb; 78(2-3):60-8. PubMed ID: 18805468
[TBL] [Abstract][Full Text] [Related]
17. Targeting the caudal intralaminar nuclei for functional neurosurgery of movement disorders.
Benabid AL
Brain Res Bull; 2009 Feb; 78(2-3):109-12. PubMed ID: 18812212
[TBL] [Abstract][Full Text] [Related]
18. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
[TBL] [Abstract][Full Text] [Related]
19. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.
Sgambato-Faure V; Cenci MA
Prog Neurobiol; 2012 Jan; 96(1):69-86. PubMed ID: 22075179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
